Hypercapnia-Induced Changes in Cerebral Blood Flow Against the Background of Experimental Cerebral Circulatory Failure
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 605535086 | ||
| 003 | CHVBK | ||
| 005 | 20210128100845.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 210128e20151001xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1007/s10517-015-3055-x |2 doi |
| 035 | |a (NATIONALLICENCE)springer-10.1007/s10517-015-3055-x | ||
| 100 | 1 | |a Kudaeva |D L. |u Department of Development and Translation of Novel Non-Pharmacological Therapies, I. M. Sechenov First Moscow State Medical University, Moskva, Russia |4 aut | |
| 245 | 1 | 0 | |a Hypercapnia-Induced Changes in Cerebral Blood Flow Against the Background of Experimental Cerebral Circulatory Failure |h [Elektronische Daten] |c [L. Kudaeva] |
| 520 | 3 | |a The peculiarities of hypercapnia-induced blood circulatory changes in the local cortical and subcortical regions of the brain and the character of disturbances of the adequate (vasodilator) responses to CO2 were examined on rabbits with experimental chronic cerebral circulatory failure. The study revealed moderation of local vasodilator effect of CO2 and reversal of the circulatory reactions to CO2 manifested in a decrease of local blood fl ow instead of its elevation. The data argue for individual use of carbogen therapy in relation to initial state of the functional organism systems. | |
| 540 | |a Springer Science+Business Media New York, 2015 | ||
| 690 | 7 | |a cerebral circulation |2 nationallicence | |
| 690 | 7 | |a hypercapnia |2 nationallicence | |
| 690 | 7 | |a cerebral circulatory failure |2 nationallicence | |
| 690 | 7 | |a carbogen therapy |2 nationallicence | |
| 773 | 0 | |t Bulletin of Experimental Biology and Medicine |d Springer US; http://www.springer-ny.com |g 159/6(2015-10-01), 712-714 |x 0007-4888 |q 159:6<712 |1 2015 |2 159 |o 10517 | |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s10517-015-3055-x |q text/html |z Onlinezugriff via DOI |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 900 | 7 | |a Metadata rights reserved |b Springer special CC-BY-NC licence |2 nationallicence | |
| 908 | |D 1 |a research-article |2 jats | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-springer | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1007/s10517-015-3055-x |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 100 |E 1- |a Kudaeva |D L. |u Department of Development and Translation of Novel Non-Pharmacological Therapies, I. M. Sechenov First Moscow State Medical University, Moskva, Russia |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Bulletin of Experimental Biology and Medicine |d Springer US; http://www.springer-ny.com |g 159/6(2015-10-01), 712-714 |x 0007-4888 |q 159:6<712 |1 2015 |2 159 |o 10517 | ||